ExpertiseUpdated on 11 February 2026
Assessment & Reimbursement decision making
About
Evidence-based regulatory advice is crucial to ensure that patients get access to the best possible new medicines. Benefit from comprehensive first-hand experience at Germany’s top health policy body, the G-BA.
Field
- Biotech, Pharma and Cosmetics
- Healthcare
Organisation
Similar opportunities
Expertise
Economic & Innovation Policy for Life Sciences
- Biotech, Pharma and Cosmetics
Noël Palushaj
Economic Policy Expert at scienceindustries
Zurich, Switzerland
Expertise
- Healthcare
- Nano and Microtechnologies
- Biotech, Pharma and Cosmetics
- Materials, Textiles and Chemicals
Sonia Thomson
Communication specialist at Biotechnet Switzerland
Muttenz, Switzerland
Expertise
Market Access and Commercial Channels Activation in Established and Emerging Markets
- Healthcare
- Biotech, Pharma and Cosmetics
Francesco Marinucci
Founder & Managing Director at Impingo Sarl
Geneva, Switzerland